Respivac aMPV (previously Respivac TRT)

Authorised

This medicine is authorised for use in the European Union

turkey rhinotracheitis virus, strain 1062, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Respivac aMPV (previously Respivac TRT)
• Active substance:
  Turkey rhinotracheitis virus, strain 1062, live
• International non-proprietary name (INN) or common name:
  turkey rhinotracheitis virus, strain 1062, live

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• Domestic fowl

Authorisation details

• EMA product number:
  EMEA/V/C/006160

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Respivac TRT

AdoptedReference Number: EMA/CVMP/136137/2024